Cellular immunotherapy for medulloblastoma

Medulloblastoma (MB) is the most common malignant brain tumor in children, making up ~20% of all primary pediatric brain tumors. Current therapies consist of maximal surgical resection and aggressive radio- and chemotherapy. A third of the treated patients cannot be cured and survivors are often lef...

Descripción completa

Detalles Bibliográficos
Autores principales: Schakelaar, Michael Y, Monnikhof, Matthijs, Crnko, Sandra, Pijnappel, Emma W, Meeldijk, Jan, ten Broeke, Toine, Bovenschen, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076947/
https://www.ncbi.nlm.nih.gov/pubmed/36219688
http://dx.doi.org/10.1093/neuonc/noac236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076947/
https://www.ncbi.nlm.nih.gov/pubmed/36219688
http://dx.doi.org/10.1093/neuonc/noac236

Ejemplares similares